Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

EYPT EyePoint Pharmaceuticals Inc

8,26

0,23 (2,86%)

04 Jan 2025 - Fermé

Retardé de 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025

Plus de graphiques de la Bourse EyePoint Pharmaceuticals

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025

Plus de graphiques de la Bourse EyePoint Pharmaceuticals

Actualités EyePoint Pharmaceuticals Inc

EyePoint to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Mardi 17 Décembre 2024 ( il y a 3 semaines) • GlobeNewswire Inc.

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Lundi 16 Décembre 2024 ( il y a 3 semaines) • GlobeNewswire Inc.

Form 8-K - Current report
Mercredi 4 Décembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

EyePoint Announces First Patient Dosed in Second Global Phase 3 LUCIA Clinical Trial of DURAVYU™ for the Treatment of Wet Age-Related Macular Degeneration
Mercredi 4 Décembre 2024 ( il y a 1 mois) • GlobeNewswire Inc.

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Lundi 18 Novembre 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jeudi 14 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jeudi 7 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Jeudi 7 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

EyePoint Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments
Jeudi 7 Novembre 2024 ( il y a 2 mois) • GlobeNewswire Inc.

EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
Lundi 4 Novembre 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Form 8-K - Current report
Jeudi 31 Octobre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
Jeudi 31 Octobre 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Plus d'articles sur EyePoint Pharmaceuticals Inc

Credit Agricole

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales